中国生化药物杂志2017,Vol.37Issue(3) :237-239.DOI:10.3969/j.issn.1005-1678.2017.03.073

氨溴索联合布地奈德雾化吸入治疗新生儿肺炎的临床效果

Clinical efficacy of ambroxol combined with budesonide aerosol inhalation in treating neonatal pneumonia

陆敏 谈健飞
中国生化药物杂志2017,Vol.37Issue(3) :237-239.DOI:10.3969/j.issn.1005-1678.2017.03.073

氨溴索联合布地奈德雾化吸入治疗新生儿肺炎的临床效果

Clinical efficacy of ambroxol combined with budesonide aerosol inhalation in treating neonatal pneumonia

陆敏 1谈健飞2
扫码查看

作者信息

  • 1. 嘉善县第一人民医院儿科,浙江嘉兴314100
  • 2. 嘉善县中医医院儿科,浙江嘉兴314100
  • 折叠

摘要

目的 观察氨溴索联合布地奈德雾化吸入治疗新生儿肺炎效果.方法 将66例肺炎患儿按随机数表法分为观察组(n=33)和对照组(n=33).观察组采用氨溴索联合布地奈德治疗,对照组采用布地奈德治疗.比较2组患儿的肺功能情况、临床效果及血流情况.结果 观察组的总有效率(93.94%)显著高于对照组(45.45%),2组比较异差异具统计学意义(P<0.05);治疗后,2组患儿的一秒用力呼气容积(forced expiratory volume in one second,FEV1)、呼气峰流速(peak expiratory flow,PEF)较治疗前均有所提高,且观察组的FEV1、PEF[(95.21±7.69)%、(93.21±7.89)%]明显高于对照组[(87.03±7.23)%、(84.55±7.45)%],2组比较差异具有统计学意义(P<0.05);2组患儿的氧指数(oxygen index,OI)较治疗前明显提高,且观察组的OI明显高于对照组,治疗后2组婴儿的动脉血二氧化碳分压(PaCO2)均明显下降且观察组显著低于对照组,2组比较差异具有统计学意义(P<0.05).结论氨溴索药联合布地奈德药治疗新生儿肺炎的疗效显著,可有效的改善婴儿肺功能,缩短治疗时间,同时也有效的改善婴儿的血流动力学.

Abstract

Objective To observe the effect of aerosol inhalation of ambroxol combined with budesonide on neonatal pneumonia .Methods 66 infants with pneumonia treated were enrolled in this study.The patients were divided into observation group ( n =33 ) and control group ( n =33 ) according to the random number method.The treatment group were treated with ambroxol combined with budesonide and the control group were treated with budesonide.The two groups of infant lung function, clinical outcomes and blood flow were compared.Results The total effective rate (93.94%) in the observation group was significantly higher than that in the control group (45.45%), there was significant difference between the two groups (P<0.05).After treatment, FEV1 and PEF in the two groups were significantly higher than those before treatment, the observation group [(95.21 ± 7.69)%, (93.21 ±7.89)%] were significantly higher than those of the control group[(87.03 ±7.23)%, (84.55 ±7.45)%], the differences between the two groups were statistically significant (P<0.05).The OI of the two groups was significantly higher than that of the control group and the OI of the observation group was significantly higher than that of the control group.PaCO2 of the two groups decreased significantly and the PaCO2 of the observation group was significantly lower than that of the control group, the difference was statistically significant ( P<0.05 ).Conclusion The combination of ambroxol and budesonide is effective in the treatment of neonatal pneumonia.It can effectively improve the infant pulmonary function, shorten the treatment time and improve the hemodynamics of infants .

关键词

新生儿肺炎/氨溴索/布地奈德/血流动力学

Key words

neonatal pneumonia/ambroxol/budesonide/hemodynamics

引用本文复制引用

出版年

2017
中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
被引量34
参考文献量8
段落导航相关论文